Stocks to Watch on April 29, 2026: Solara Active, Wanbury, Enviro Infra, Mobikwik, BHEL, Sanofi Consumer and Others

In the previous trading session, benchmark indices traded cautiously as investors remained attentive to global cues and a series of domestic corporate developments. 

Market participants are expected to closely track earnings announcements, regulatory inspections, strategic acquisitions and bulk deals, which could drive stock-specific movements in today’s session. 

Solara Active Pharma Sciences 

Solara Active Pharma Sciences’s Ibuprofen manufacturing facility in Puducherry has successfully completed an unannounced inspection by the US Food and Drug Administration (US FDA). The inspection concluded with a Voluntary Action Indicated (VAI) classification, and the facility has received an Establishment Inspection Report (EIR), signalling closure of the inspection. 

Wanbury Ltd 

Wanbury’s Patalganga facility underwent a regulatory inspection by the Ministry of Food and Drug Safety (Korea FDA). Conducted over three days from April 7 to 9, the inspection concluded with zero observations, indicating strong compliance standards. 

Enviro Infra Engineers Ltd 

Enviro Infra Engineers’s subsidiary, EIE Renewables, has entered into a share purchase agreement to acquire 100 percent stake in Suyog Urja for ₹311 crore in phases. An initial 51 percent stake will be acquired immediately, with the remaining 49 percent to be completed within 27 months. 

Bharat Heavy Electricals Ltd (BHEL) 

BHEL has signed a licensing agreement for transfer of technology with NSTL-DRDO, Visakhapatnam, for the fabrication and commissioning of the LM2500 Gas Turbine Infrared Suppression System for naval vessels, strengthening its presence in the defence segment. 

One Mobikwik Systems Ltd 

Peak XV Partners Investments IV exited its entire 7.89 percent stake in One Mobikwik Systems through a bulk deal worth ₹133.01 crore. Meanwhile, investors including Viridian Asia Opportunities Master Fund, Societe Generale and Elimath Advisors acquired shares, indicating continued investor interest. 

Read More: SEBI Penalises 8 Entities in Front-Running Case, Orders ₹1.29 Crore Disgorgement! 

Sanofi Consumer Healthcare India 

Sanofi Consumer Healthcare India reported a 35.6 percent year-on-year rise in profit to ₹67.8 crore, while revenue increased 32.8 percent to ₹229.2 crore, reflecting strong growth in its consumer healthcare portfolio. 

Fedbank Financial Services Ltd 

Fedbank Financial Services posted a 40.3 percent year-on-year increase in profit at ₹100.5 crore. Net interest income also rose significantly by 23.1 percent, highlighting steady growth in its lending business. 

Greenply Industries Ltd 

Greenply reported robust financial performance with profit rising 86.4 percent year-on-year to ₹30.7 crore, supported by a 19.6 percent increase in revenue. Additionally, the company announced the resignation of its Joint Managing Director and CEO, effective May 1. 

Ceat Ltd 

The tyre manufacturer, Ceat posted a sharp 145.1 percent jump in consolidated profit to ₹243.85 crore, with revenue growing 23.3 percent, reflecting strong operational performance. 

Garden Reach Shipbuilders & Engineers Ltd 

Garden Reach Shipbuilders & Engineers reported a 24.1 percent rise in profit to ₹303.2 crore, while revenue surged 29 percent year-on-year, supported by strong execution in defence shipbuilding projects. 

Other Stocks in Focus 

Stocks such as Bandhan Bank, Orient Cement and Star Health and Allied Insurance Company will also remain on investors’ radar following their latest quarterly earnings announcements and operational updates. 

Conclusion 

Regulatory clearances, strategic acquisitions, strong earnings performance and bulk deal activity are expected to drive stock-specific action in today’s trading session. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.